Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 11/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 13/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | POLB | P06746 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL368265 | 0.74 | MAPT (0.56) | MAPTALDH1A1KDM4EPOLBTSHR | |
| SCHEMBL569284 | 0.74 | — | — | |
| SCHEMBL27498457 | 0.72 | MAPT (0.54) | MAPTALDH1A1KDM4EPOLBTSHR | |
| SCHEMBL432006 | 0.72 | MAPT (0.54) | MAPTALDH1A1KDM4EPOLBTSHR | |
| SCHEMBL20036958 | 0.72 | MAPT (0.54) | MAPTALDH1A1KDM4EPOLBTSHR | |
| SCHEMBL305185 | 0.72 | MAPT (0.54) | MAPTALDH1A1KDM4EPOLBTSHR | |
| SCHEMBL11304206 | 0.72 | ALDH1A1 (0.59) | MAPTALDH1A1KDM4EPOLBTSHR | |
| SCHEMBL313930 | 0.72 | ALDH1A1 (0.59) | MAPTALDH1A1KDM4EPOLBTSHR | |
| SCHEMBL8675518 | 0.72 | MAPT (0.43) | MAPTALDH1A1KDM4EPOLBTSHR | |
| SCHEMBL313967 | 0.70 | ALDH1A1 (0.57) | MAPTALDH1A1KDM4EPOLBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3713496-B1 | ULTRASOUND SUSCEPTIBLE MAGNETIC DIRECTED NANO DRUG CARRIER SYSTEM | EGE UNIV (TR) | 2025-07-23 | — | — | EP | claimed |
| US-20260137803-A1 | LIPID NANOPARTICLES AND METHODS OF MANUFACTURE AND USE THEREOF | GENZYME CORP (US) | 2026-05-21 | — | — | US | disclosed |
| US-20250388910-A1 | METHODS FOR ENHANCING MICROBIAL PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS IN THE PRESENCE OF METHANOL | AGAIN BIO APS (DK) | 2025-12-25 | — | — | US | disclosed |
| US-12484369-B2 | Composite material and quantum dot light emitting diode | TCL TECHNOLOGY GROUP CORPORATION (CN) | 2025-11-25 | — | — | US | disclosed |
| US-12398396-B2 | Methods for enhancing microbial production of specific length fatty alcohols in the presence of methanol | GENOMATICA, INC. (US) | 2025-08-26 | — | — | US | disclosed |
| US-12377069-B2 | Compounds, compositions, methods of using, and methods for preparing compounds | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| EP-4577185-A1 | AQUEOUS PERSONAL CARE RINSE OFF COMPOSITION | Dow Global Technologies LLC (US) | 2025-07-02 | — | — | EP | disclosed |
| EP-4577630-A1 | AQUEOUS LIGHT DUTY LIQUID DETERGENT FORMULATION | Dow Global Technologies LLC (US) | 2025-07-02 | — | — | EP | disclosed |
| EP-4577629-A1 | AQUEOUS LAUNDRY DETERGENT COMPOSITION | Dow Global Technologies LLC (US) | 2025-07-02 | — | — | EP | disclosed |
| US-12331056-B2 | SHP2 phosphatase inhibitors and methods of use thereof | RELAY THERAPEUTICS, INC. (US) | 2025-06-17 | — | — | US | disclosed |
| CN-110719902-B | SSAO inhibitors | 山东丹红制药有限公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-114621190-A | Allylamine derivative and application thereof | 上海拓界生物医药科技有限公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-114621189-A | Lactam derivative and application thereof | 上海拓界生物医药科技有限公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-114478302-A | Sitagliptin impurity and preparation method thereof | 江苏万邦生化医药集团有限责任公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-109476668-B | 6, 7-dihydro-4H-pyrazolo [1,5-a ] pyrazines and 6, 7-dihydro-4H-triazolo [1,5-a ] pyrazines for the treatment of infectious diseases | 豪夫迈·罗氏有限公司 | 2022-03-22 | — | — | CN | disclosed |
| US-20220064197-A1 | PHOSPHINE OXIDE GROUP-CONTAINED TRANSITION METAL COMPLEX, AND POLYMER, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC DEVICE THEREOF | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2022-03-03 | — | — | US | disclosed |
| EP-0437594-B1 | OXIDATION CATALYSTS BASED ON METALLOPORPHYRINE ON A SUBSTRATE | ELF AQUITAINE (FR) | 1994-07-27 | — | — | EP | disclosed |
| US-5141911-A | Bonding to organonitrogen polymer | SOCIETE NATIONALE ELF AQUITAINE (FR) | 1992-08-25 | — | — | US | disclosed |
| EP-0437594-A1 | OXIDATION CATALYSTS BASED ON METALLOPORPHYRINE ON A SUBSTRATE. | ELF AQUITAINE (FR) | 1991-07-24 | — | — | EP | disclosed |
| WO-1991001806-A1 | OXIDATION CATALYSTS BASED ON METALLOPORPHYRINE ON A SUBSTRATE | SOCIETE NATIONALE ELF AQUITAINE (FR) | 1991-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388910-A1 | METHODS FOR ENHANCING MICROBIAL PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS IN THE PRESENCE OF METHANOL | ADH5, ADH1C, ADH1A | MAPT 4434/4885ALDH1A1 94/4885KDM4E 842/4885 |
| US-12377069-B2 | Compounds, compositions, methods of using, and methods for preparing compounds | UTS2R, REN, UMPS | MAPT 641/4885ALDH1A1 214/4885KDM4E 1913/4885 |
| US-12331056-B2 | SHP2 phosphatase inhibitors and methods of use thereof | PTPRCAP, PTPN22, PTPN1 | MAPT 4685/4885ALDH1A1 3280/4885KDM4E 756/4885 |
| US-20260137803-A1 | LIPID NANOPARTICLES AND METHODS OF MANUFACTURE AND USE THEREOF | CD2BP2, CD2, CD4 | MAPT 3846/4885ALDH1A1 2958/4885KDM4E 2249/4885 |
| US-20220064197-A1 | PHOSPHINE OXIDE GROUP-CONTAINED TRANSITION METAL COMPLEX, AND POLYMER, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC DEVICE THEREOF | PHOSPHO1, CPNE4, TCP1 | MAPT 1347/4885ALDH1A1 4298/4885KDM4E 2651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.